Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-113696
Filing Date
2024-10-09
Accepted
2024-10-09 14:35:28
Documents
1
Period of Report
2024-10-01

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1491
  Complete submission text file 0000950170-24-113696.txt   3213
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Issuer) CIK: 0000822370 (see all company filings)

EIN.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 21250 HAWTHORNE BOULEVARD SUITE 800 TORRANCE CA 90503
Business Address
Kuwahara Jon (Reporting) CIK: 0001664784 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35527 | Film No.: 241362468